Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Portola Capital Partners

Portola Capital Partners?uq=2zON1W4M
VC INVESTOR TYPE
Active STATUS
2 PROFESSIONALS
2 INVESTMENTS
2 EXITS
Description

Portola Capital Partners is a healthcare investment and advisory firm that focuses on innovation, growth and cross-border deals in North America, Asia, Europe and emerging markets. The firm also focuses on investing in emerging public and private biotechnology and device companies.

Investor Status
Actively Seeking New Investments
Year Founded
2010
Primary Investor Type
Venture Capital
Primary Office
  • 450 Lexington Avenue
  • Suite 39B
  • New York, NY 10017
  • United States

Portola Capital Partners Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Aptinyx 15-Sep-2015 Seed Round Drug Discovery Startup
000000 02-Dec-2014 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Portola Capital Partners’s full profile, request a free trial.

Portola Capital Partners Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
Aptinyx 21-Jun-2018 IPO 00000 Completed
000000 28-Aug-2015 000000000000000000 00.000 Completed
  • 00000000
To view this investor’s complete exits history, request access »

Portola Capital Partners Team (2)

Name Title Deals Funds Boards Office Contact
Info
Greg Spalasso Executive New York, NY
Sasha Blaug Ph.D Senior Investment Analyst & Vice President New York, NY